Stay updated on Senolytic Therapy in Alzheimer's Clinical Trial

Sign up to get notified when there's something new on the Senolytic Therapy in Alzheimer's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Senolytic Therapy in Alzheimer's Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added a dedicated North Carolina locations section to the Study Details page and removed/renamed the North Carolina Locations header along with the HHS Vulnerability Disclosure link, reflecting a reorganization of site location and footer elements.
    Difference
    0.2%
    Check dated 2025-12-23T17:17:08.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Publications section description updated to indicate automatic population from PubMed and notes the revision to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T21:49:26.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Removed a site-wide funding-status notice from the page. The core study details and participation information remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T20:03:15.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    No significant content changes detected; only administrative updates such as the last update timestamp and minor UI adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:47:09.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Update adds a government funding status notice and NIH Clinical Center operating details, and upgrades the version from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-06T04:22:54.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Added new version tag v3.1.0 and removed multiple drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs, plus an earlier version v3.0.2). The core effect is a reorganization that reduces coverage of safety topics.
    Difference
    0.4%
    Check dated 2025-09-28T23:39:29.000Z thumbnail image

Stay in the know with updates to Senolytic Therapy in Alzheimer's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Senolytic Therapy in Alzheimer's Clinical Trial page.